Newsroom

The issue: The single source vendor of lidocaine 1% and 2% with EPINEPHrine 1:100,000 X 20 mL vials is on backorder. Several NH sites have low stock in pharmacies and wardstock areas, and alternate options will need to be used when supply is depleted.

The issue: The single source vendor of betamethasone 6 mg/mL injection (1 mL and 5 mL vials) is on backorder. NH has approximately 6-7 weeks of stock in pharmacies and clinical areas, and the alternate option will need to be used when supply is depleted.

The issue: Erythromycin 333 mg SR oral tablets (ERYC®) have been discontinued in Canada, and there are no other solid oral erythromycin dosage forms currently available. NH has low stock remaining.

COVID-19 testing performed on ID NOW instruments in emergency rooms across NHA has been permanently discontinued, effective immediately.

March 2023 formulary update - effective March 24, 2023

Included in the update:

NH laboratory services is investigating making revisions to the Drugs of Abuse (DOA) test panels offered in our region, and are seeking stakeholder feedback.

The issue: Methotrimeprazine 25 mg/mL x 1 mL injectable is available but still in short supply. NH pharmacy is able to access stock on a weekly basis, but it may not be enough to meet local demand.